Selvedge Venture
Venture capitalPre-Seed–Series A · 3 people tracked
Investment thesis
Selvedge Venture invests in mission-driven founders and startups addressing age-related medical conditions, which account for over 60% of human mortality. The firm focuses specifically on metabolic syndrome (cardiovascular disease, diabetes, fatty liver disease, obesity), cancer, and neurodegenerative diseases. The investment strategy leverages the intersection of biotechnology and digital technologies, emphasizing data-centric approaches and machine learning tools to create, curate, and exploit novel healthcare and life sciences data related to these conditions.
Source: firm website, verified Jul 21, 2026.
Team · 3 people
from the firm's websiteFounder of Selvedge Venture who is passionate about deep technology's potential to transform life sciences and healthcare.
Co-founder with over 30 years of biopharma and healthcare experience, having worked with more than 100 organizations across 14 countries and previously served as co-head of the Life Sciences Group at Capgemini.
Joined as part of the founding team in August 2020 to lead investor relations, with a focus on US and Middle East markets.
Investments · 9 tracked
founders shown can be your intro pathFrequently asked questions
- What stage does Selvedge Venture invest at?
- Selvedge Venture invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Selvedge Venture focus on?
- Selvedge Venture focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
An AI-first venture capital firm founded in 2016 that invests across the full AI stack, including next-generation compute chips, AI infrastructure, robotics, and agentic AI solutions. The team originated from Stanford and leverages deep domain expertise and access to frontier research talent.
Hyderabad Angels is a collective of experienced entrepreneurs, industrialists, and family offices founded in 2010 that provides mentorship, capital, and network access to early-stage founders. The organization invests in seed and pre-seed companies across sector-agnostic technology, healthcare, consumer, and other emerging sectors.